NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699
Open Access
- 27 June 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 31 (2), 251-264
- https://doi.org/10.1038/onc.2011.229
Abstract
The stress-inducible transcription factor, nuclear factor (NF)-κB induces genes involved in proliferation and apoptosis. Aberrant NF-κB activity is common in cancer and contributes to therapeutic-resistance. Poly(ADP-ribose) polymerase-1 (PARP-1) is activated during DNA strand break repair and is a known transcriptional co-regulator. Here, we investigated the role of PARP-1 function during NF-κB activation using p65 small interfering RNA (siRNA), PARP siRNA or the potent PARP-1 inhibitor, AG-014699. Survival and apoptosis assays showed that NF-κB p65−/− cells were more sensitive to ionizing radiation (IR) than p65+/+ cells. Co-incubation with p65 siRNA, PARP siRNA or AG-014699 radio-sensitized p65+/+, but not p65−/− cells, demonstrating that PARP-1 mediates its effects on survival via NF-κB. Single-strand break (SSB) repair kinetics, and the effect SSB repair inhibition by AG-014699 were similar in p65+/+ and p65−/− cells. As preventing SSB repair did not radio-sensitize p65−/− cells, we conclude that radio-sensitization by AG-014699 is due to downstream inhibition of NF-κB activation, and independent of SSB repair inhibition. PARP-1 catalytic activity was essential for IR-induced p65 DNA binding and NF-κB-dependent gene transcription, whereas for tumor necrosis factor (TNF)-α-treated cells, PARP-1 protein alone was sufficient. We hypothesize that this stimulus-dependent differential is mediated via stimulation of the poly(ADP-ribose) polymer, which was induced following IR, not TNF-α. Targeting DNA damage-activated NF-κB using AG-014699 may therefore overcome toxicity observed with classical NF-κB inhibitors without compromising other vital inflammatory functions. These data highlight the potential of PARP-1 inhibitors to overcome NF-κB-mediated therapeutic resistance and widens the spectrum of cancers in which these agents may be utilized.Keywords
This publication has 59 references indexed in Scilit:
- The IKK complex contributes to the induction of autophagyThe EMBO Journal, 2009
- NF-κB and cancer: how intimate is this relationshipMolecular and Cellular Biochemistry, 2009
- Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell linesBritish Journal of Cancer, 2009
- Inhibition of Poly(ADP-Ribose) Polymerase-1 Enhances Temozolomide and Topotecan Activity against Childhood NeuroblastomaClinical Cancer Research, 2009
- Ionizing radiation-induced NF-κB activation requires PARP-1 function to confer radioresistanceOncogene, 2008
- Phase I Study of the Poly (ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid TumorsClinical Cancer Research, 2008
- Inhibitors of NF-κB signaling: 785 and countingOncogene, 2006
- Inhibition of Poly(ADP-Ribose) Polymerase Modulates Tumor-Related Gene Expression, Including Hypoxia-Inducible Factor-1 Activation, during Skin CarcinogenesisCancer Research, 2006
- NF-κB/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitorsLeukemia, 2003
- NF-κB signaling pathway as a target for human tumor radiosensitizationSeminars in Radiation Oncology, 2001